Amrutanjan Health Care Limited has formally notified stock exchanges about its upcoming board meeting scheduled for Friday, May 8, 2026. The meeting will be conducted through video conferencing and aims to address key financial matters for the concluded financial year.

Board Meeting Agenda

The board of directors will deliberate on two primary agenda items during the scheduled meeting:

The meeting has been convened in accordance with Regulation 29(1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, ensuring compliance with regulatory requirements for listed companies.

Trading Window Restrictions

Amrutanjan Health Care Limited has implemented trading window restrictions as part of its compliance framework. The company previously informed stakeholders on March 24, 2026, about the closure of the trading window for dealing in equity shares.

These restrictions align with the company's Code of Conduct designed to regulate, monitor and report trading in securities, ensuring adherence to insider trading regulations during the financial results announcement period.

Regulatory Compliance

The notification was issued by Gagan Preet Singh, General Manager - Legal, Company Secretary & Compliance Officer, and digitally signed on April 30, 2026. The communication was addressed to both the National Stock Exchange of India Limited and BSE Limited, maintaining transparency with all relevant stakeholders and regulatory bodies.

Amrutanjan Health Care Limited announced on 17 April 2026 the launch of a new range of products across Personal Care, Wound Care, and Pain Management categories. The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company disclosed these developments through a detailed filing to the National Stock Exchange of India Limited and BSE Limited.

Personal Care Segment

The company marked its strategic entry into the razors category, expanding into the fast-growing grooming segment. The Personal Care portfolio includes three new products:

Developed using advanced Korean technology, the women's razor range under the Comfy brand represents an extension of the company's vision to build a comprehensive women's wellness and personal care portfolio. The men's razor range enables entry into the male grooming segment, leveraging brand trust to unlock new growth avenues.

Wound Care Portfolio

Amrutanjan introduced Amrutanjan Plastry, a range of medicated antiseptic plasters leveraging the company's trusted equity in pain relief and care. The product range includes Regular and Wash proof variants offered in a convenient jar format. Key product features include breathable fabric, strong adhesion, and protection against bacteria and water. The jar contains 100 Regular and 70 Washproof variants, designed for ease of use and storage.

Pain Management Expansion

The company launched Amrutanjan Ortho Pain Relief + Oil, a significant addition to its pain management portfolio. The product features an advanced heat therapy formulation enriched with Gandhapura and Capsaicin. According to clinical evidence, the oil provides up to 66% pain reduction in 8 weeks of usage. The product is designed for targeted relief from back, shoulder, joint, and muscular pain along with stiffness. The packaging includes a 20% extra volume offering and is positioned as a 100% Ayurvedic solution for Osteoarthritis and Rheumatoid Arthritis.

Product Launch Summary

The launches represent the company's strategy to strengthen its portfolio through relevant and high-utility categories while expanding presence in high-growth segments.